Liposomes Produced by Microfluidics and Extrusion: A Comparison for Scale-up Purposes


Authors: V.M. Shah, D.X. Nguyen, P. Patel, B. Cote, A. Al-Fatease, Y. Pham, M.G. Huynh, Y. Woo, and A.W.G. Alani.

Journal: Nanomedicine: Nanotechnology, Biology and Medicine

DOI: 10.1016/j.nano.2019.02.019

Publication - Abstract

March 13, 2019

Abstract

Successful liposomal formulations in the clinic are severely limited due to poor translational capability of the traditional bench techniques to clinical production settings. The gold standard for liposome bench manufacturing is a multi-step and parameter dependent extrusion method. Moreover, these parameters need re-optimization for clinical production. The microfluidics technique utilizes vigorous mixing of fluids at a nanoliter scale to produce liposomes in batches from milliliters to a couple liters. The fine control of process parameters results in improved reproducibility between batches. It is inherently scalable; however, the characteristics of liposomes produced by microfluidics both in vitro and in vivo have never been compared to those produced using extrusion. In this manuscript, we describe the comparison between the traditional extrusion method to microfluidics, the new paradigm in liposome production and scale-up.

Advanced Search

close
  • Publications
  • Application Notes
  • Posters
  • Workshops
  • Videos & Webinars
  • Articles
Search

Browse by Category

  • Application
    • Diagnostic and Imaging
    • Genetic Medicine
    • Hematology
    • Metabolic Disorders
    • Neuroscience
    • Oncology
    • Skeletal Disorders
    • Targeted Drug Delivery
    • Vaccines
    • Other Applications
    • Cell therapy
  • Formulation
    • Liposomes
    • Nucleic Acid Lipid Nanoparticles
    • Polymeric Nanoparticles
    • Other Formulations
  • Payload
    • DNA
    • microRNA
    • mRNA
    • siRNA
    • Small Molecule Drugs
    • Other Payloads


related content

Publication - Abstract

Using Microfluidics for Scalable Manufacturing of Nanomedicines from Bench to GMP: A Case Study Using Protein-loaded Liposomes

C. Webb, N. Forbes, C.B. Roces, G. Anderluzzi, G. Lou, S. Abraham, L. Ingalls, K. Marshall, T.J. Leaver, J.A. Watts, J.W. Aylott, and Y. Perrie

In a 2020 study conducted by researchers at the University of Strathclyde Institute of Pharmacy and Biomedical Sciences, a scale-by-scale development of genetic medicines from bench to GMP was outlined through the generation of liposomes with a protein payload using two different...
Read More


Publication - Summary

Zebrafish as a Predictive Screening Model to Assess Macrophage Clearance of Liposomes In Vivo

S. Sieber, P. Grossen, P. Uhl, P. Detampel, W. Mier, D. Witzigmann, J. Huwyler

The Witzigmann and Huwyler labs at the University of Basel examined the in vivo clearance of previously approved liposome formulations in zebrafish embryos and rats to demonstrate that zebrafish embryos provide similar results while being are a cheaper and faster to stud...
Read More


Sign Up and Stay Informed
Sign up today to automatically receive new Cytiva, formerly Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.